Eagle Pharmaceuticals, Inc. Operating Lease, Expense
Eagle Pharmaceuticals, Inc. reported Operating Lease, Expense of $325.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-11-09
- Eagle Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-09-30 was $325.00K, a 17.75% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-06-30 was $325.00K, a 7.41% decline year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-03-31 was $325.00K, a 13.64% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2020-09-30 was $276.00K, a 3.50% decline year-over-year.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $325.00K 10-Q · filed 2021-11-09 | $650.00K derived: sum of 2 quarters · filed 2021-11-09 | $976.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $325.00K 10-Q · filed 2021-08-09 | $650.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $325.00K 10-Q · filed 2021-05-10 | ||
| 2020-09-30 | $276.00K 10-Q · filed 2021-11-09 | $627.00K derived: sum of 2 quarters · filed 2021-11-09 | $910.00K 10-Q · filed 2021-11-09 |
| 2020-06-30 | $351.00K 10-Q · filed 2021-08-09 | $637.00K 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $286.00K 10-Q · filed 2021-05-10 | ||
| 2019-09-30 | $286.00K 10-Q · filed 2020-11-02 | $573.00K derived: sum of 2 quarters · filed 2020-11-02 | $860.00K 10-Q · filed 2020-11-02 |
| 2019-06-30 | $287.00K 10-Q · filed 2020-08-10 | $573.00K 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $287.00K 10-Q · filed 2020-05-11 |